Raul E. R.
- Country
- Spain
- Department
- #5415 :neurologia
Research Overview
- A Randomized, Double-Blind Study Comparing Remibrutinib and Teriflunomide in Relapsing Multiple Sclerosis Patients, with Open-Label Remibrutinib Extension
- Evaluation of Efficacy, Safety, and Pharmacokinetics of Increased Ocrelizumab Dose in Adults with Relapsing Multiple Sclerosis: A Phase IIIb Randomized Controlled Trial
- A Phase III Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared with Ocrelizumab in Adult Patients with Primary Progressive Multiple Sclerosis
Data & Insights
Has run more than one trial at 74 of 203 partner sites.
Specializations
Neuroimmunology and Multiple Sclerosis
Clinical research interests include relapsing and progressive forms of multiple sclerosis, with attention to therapies that target inflammatory activity, relapse control, disability progression, and fatigue management.
- Relapsing multiple sclerosis
- Primary progressive multiple sclerosis
- Fatigue in multiple sclerosis
- Anti-inflammatory and disease-modifying therapy
Work in this area also extends to treatment strategies for symptom burden and long-term neurologic function.
Bladder Cancer and Urothelial Oncology
Research activity covers non-muscle-invasive and muscle-invasive bladder cancer, including high-risk disease, carcinoma in situ, and tumors with FGFR alterations, with interest in intravesical and systemic oncologic approaches.
- High-risk non-muscle-invasive bladder cancer
- Muscle-invasive urothelial carcinoma
- FGFR-altered urothelial cancer
- Adjuvant and bladder-preserving therapy
This field includes therapeutic evaluation of treatments intended to improve disease control and preserve bladder function.
Prostate Cancer and Genitourinary Oncology
The investigator is involved in studies of high-risk and metastatic prostate cancer, including hormone-sensitive, castration-resistant, and recurrent settings, with emphasis on treatment intensification and progression control.
- High-risk localized prostate cancer
- Metastatic hormone-sensitive prostate cancer
- Metastatic castration-resistant prostate cancer
- Androgen deprivation-based therapy
Research in this domain also includes imaging-guided therapeutic decision-making and perioperative management.
Respiratory, Fibrotic, and Critical Care Conditions
Clinical interests include idiopathic pulmonary fibrosis, progressive pulmonary fibrosis, severe asthma, and septic shock, reflecting involvement in chronic lung disease and acute intensive care medicine.
- Idiopathic pulmonary fibrosis
- Progressive pulmonary fibrosis
- Eosinophilic asthma
- Septic shock
Additional activity includes therapeutic evaluation in infection-related and organ-failure settings.
Inflammatory, Cardiometabolic, and Neurologic Symptom Disorders
Research also spans hidradenitis suppurativa, chronic spontaneous urticaria, migraine, medication overuse headache, vitiligo, and cardiometabolic conditions such as severe hypertriglyceridemia and chronic kidney disease-associated vascular risk.
- Hidradenitis suppurativa
- Chronic spontaneous urticaria
- Migraine and medication overuse headache
- Severe hypertriglyceridemia
These areas reflect interest in immune-mediated skin disease, headache disorders, and metabolic-cardiovascular risk reduction.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.